← Every company
Castle Biosciences Inc Patents
What Castle Biosciences Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
CSTL on carbonthat →Filings on file
13
Granted
0
Still pending
13
Filed under
2 names
13 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/112, C12Q2600/118, C12Q2600/158Filed as CASTLE BIOSCIENCES, INC.2026-05-13Robert Willis COOK | pending |
| DIAGNOSING AND TREATMENT UVEAL MELANOMAFiled as CASTLE BIOSCIENCES, INC.2026-02-27OLGA CAIN | pending |
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/112, C12Q2600/118, C12Q2600/158Filed as CASTLE BIOSCIENCES, INC.2025-12-08Robert Willis COOK | pending |
| METHOD AND KIT FOR ISOLATING AND SEQUENCING NUCLEIC ACID FROM SKIN SAMPLESFiled as CASTLE BIOSCIENCES, INC.2025-08-11OLGA CAIN | pending |
| DIAGNOSTIC TEST FOR PREDICTING METASTASIS AND RECURRENCE IN CUTANEOUS MELANOMAC12Q 1/6886, C12Q2600/118, C12Q2600/158Filed as Castle Biosciences, Inc.2025-07-21Robert Willis COOK | pending |
| DIAGNOSTIC TEST FOR PREDICTING METASTASIS AND RECURRENCE IN CUTANEOUS MELANOMAC12Q 1/6886, C12Q2600/118, C12Q2600/158Filed as Castle Biosciences, Inc.2025-06-17Robert Willis COOK | pending |
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/118, C12Q2600/158, C12Q2600/112Filed as CASTLE BIOSCIENCES, INC.2025-03-21Robert Willis COOK | pending |
| DIAGNOSING AND TREATING UVEAL MELANOMAFiled as Castle Biosciences, Inc.2025-02-28Olga CAIN | pending |
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/118, C12Q2600/158Filed as CASTLE BIOSCIENCES, INC.2025-01-03Robert Willis COOK | pending |
| METHOD AND KIT FOR ISOLATING AND SEQUENCING NUCLEIC ACID FROM SKIN SAMPLESFiled as Castle Biosciences, Inc.2024-08-09Olga CAIN | pending |
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/118, C12Q2600/158Filed as CASTLE BIOSCIENCES, INC.2024-04-04Robert Willis COOK | pending |
| METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMAC12Q 1/6886, C12Q2600/106, C12Q2600/118, C12Q2600/158Filed as CASTLE BIOSCIENCES, INC.2024-04-04Robert Willis COOK | pending |
| DIAGNOSING AND TREATING ATOPIC DERMATITIS, PSORIASIS, AND/OR MYCOSIS FUNGOIDESFiled as CASTLE BIOSCIENCES, INC.2024-03-11DEREK MAETZOLD | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on CSTL
Company overviewEverything on CSTL in one place, with the price.SEC filingsWhat CSTL's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat CSTL's own officers and directors buy and sell.Planned salesSales CSTL insiders have filed notice of.Executive payWhat CSTL awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CSTL.Funds holding itWhich funds and ETFs hold CSTL, and how big a bet.LobbyingWhat CSTL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on CSTL's account, and who they worked for.Federal contractsWhat federal agencies pay CSTL.